‌

US Patent 7507763 Resistance-repellent retroviral protease inhibitors

Patent 7507763 was granted and assigned to Sequoia Pharmaceuticals on March, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Sequoia Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7507763

Date of Patent

March 24, 2009

Patent Application Number

11490261

Date Filed

July 21, 2006

Patent Primary Examiner

‌

Kamal A Saeed

Patent abstract

Resistance-repellent and multidrug resistant retroviral protease inhibitors are provided. Pharmaceutical composition comprising such compounds, and methods of using such compounds to treat HIV infections in mammals, are also provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7507763 Resistance-repellent retroviral protease inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API